Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy.

[1]  R. Kanamaru,et al.  Enhancement of chemotherapeutic effects with focused shock waves: extracorporeal shock wave chemotherapy (ESWC). , 1996, Human cell.

[2]  K. Ono,et al.  Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. , 1996, International journal of radiation oncology, biology, physics.

[3]  Jay S. Loeffler,et al.  Radiation Oncology: Technology and Biology , 1994 .

[4]  T. Buchholz,et al.  Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy. , 1994, International journal of radiation oncology, biology, physics.

[5]  J. Kalef-Ezra,et al.  In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. , 1990, Cancer research.

[6]  R. Barth,et al.  Boron neutron capture therapy of cancer. , 1990, Cancer research.

[7]  J. Vienken,et al.  Development of drug carrier systems: Electrical field induced effects in cell membranes* , 1980 .

[8]  H. Hatanaka.  Boron-Neutron Capture Therapy for Tumors , 1986 .

[9]  Tooru Kobayashi,et al.  Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry , 1983 .

[10]  T. Kobatashi.  Microanalysis system of ppm-order ^ B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry , 1983 .